/
Countries using and planning to introduce IPV Countries using and planning to introduce IPV

Countries using and planning to introduce IPV - PowerPoint Presentation

luanne-stotts
luanne-stotts . @luanne-stotts
Follow
396 views
Uploaded On 2016-05-16

Countries using and planning to introduce IPV - PPT Presentation

a nd the global status of bOPV registration Countries using and planning to introduce IPV October 2015 status report This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine IPV ID: 321828

countries 2015 2014 amp 2015 countries amp 2014 ipv october introduce date world 2013 status boundaries organization health lines

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Countries using and planning to introduc..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Countries using and planning to introduce IPV

a

nd the global status of bOPV registrationSlide2

Countries using and planning to introduce IPVOctober 2015 status report

This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV).

It also includes a summary of the global status of national registration of bivalent Oral Polio Vaccine (

bOPV

), in preparation for the switch from trivalent OPV (

tOPV

) to

bOPV

.

Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact

polio2@who.int

with any questions or updates on this data.

Definitions

Formal decision

to introduce:

The country has documentation of its decision

to introduce

IPV which has

been verified by the relevant WHO Regional

Office, or for GAVI eligible countries, a complete application for IPV has been submitted to the GAVI Secretariat.

Intent

to introduce:

The country has informally indicated that it plans to introduce IPV, e.g. planning an application

to

GAVI, or by requesting technical

assistance to

develop an

IPV introduction

plan.

Tracking

these

decisions and informal

intents provide an indication of the global trend towards meeting

the targets of the

Polio Eradication and Endgame Strategic Plan

.Slide3

Countries using IPV vaccine to date

and formal decision to introduceSince January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Kiribati, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015)

Data source: WHO/IVB Database, as of 01 October 2015

Map production Immunization Vaccines and Biologicals (IVB),

World Health Organization

Date of slide: 1 October 2015

The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.

Introduced to date

(111 countries or 57.2%)

Formal commitment to introduce in 2015

(50 countries or 25.8%)

Formal commitment / Introduction delayed to 2016 due to global IPV vaccine shortage

(33 countries or 17%)

Not applicableSlide4

Countries using IPV vaccine to date and introductions planned according to Gavi

eligibility statusData source: WHO/IVB Database, as of 01 October 2015Map production Immunization Vaccines and Biologicals (IVB),

World Health Organization

Date of slide: 1 October 2015

The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.

Introduced to date

(111 countries or 57.2%)

Gavi

countries with formal commitment to introduce in 2015-2016

(48 countries or 24.8%)

Non

Gavi

countries with formal commitment to introduce in 2015-2016

(35 countries or 18%)

Not applicable

Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Kiribati, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015)Slide5

83 countries introducing IPV between 1

st October 2015 and September 2016

Tier

1 countries

are countries

with

cVDPV2 transmission or

cVDPV2 reported since 2000 & WPV endemic

countriesTier 2 countries are countries

with cVDPV 1/3 since 2000 or large /medium size countries with DTP3 coverage <80% in the past 3

years as per WUENIC Source: WHO/UNICEF database as at

01 October 2015

Mauritius is introducing in 2016 but no month

of introduction available. Slide6

Tier 1 and 2 Countries using IPV vaccine to date

and formal decision to introduce

Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries

Tier 2 countries are countries with

cVDPV

1/3 since 2000 or large /Medium size countries

with DTP3 coverage <80% in the past 3 years as per WUENIC

Data source: WHO/IVB Database, as of 01 October 2015,

based on 36 tier 1 & 2 countries

Map production Immunization Vaccines and Biologicals (IVB),

World Health OrganizationDate of slide: 1 October 2015

The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.

Introduced to date

(19 countries or 52.8%)

Formal commitment to introduce in 2015

(13 countries or 36.1%)

Not Applicable or not Tier 1 or 2 countries

(158 countries )

Since January 2013, the following Tier 1 and 2 countries have introduced IPV:

The Philippines (October 2014), China (December 2014), Nigeria (February 2015), DR Congo (April 2015), Madagascar (May 2015), Cameroon, Niger and Pakistan (July 2015); Benin, Chad and Papua New Guinea (August 2015); Afghanistan and CAR (September 2015)

Formal commitment to introduce in 2016

(4 countries or 11.1%)Slide7

Middle Income Countries using IPV vaccine to date

and formal/intent decision to introduceData source: WHO/IVB Database, as of 01 October 2015 based on 100middle income countries (MIC) as per last World Bank classification

Map production Immunization Vaccines and Biologicals (IVB),

World Health Organization

Date of slide: 1 October 2015

The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.

Introduced to date

(49 countries or 49%)

Formal commitment to introduce in 2015

(51 countries or 51%)

Formal commitment to introduce in 2016

(19 countries or 19%)

Not available / Not applicable / Non MIC countries

Since January 2013, the following MIC have introduced IPV:

Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015);

M

aldives (March 2015) and Cote d'Ivoire, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015);

Bhutan

, Cameroon,

Pakistan & Sri Lanka (July 2015

); Papua New Guinea & the former Yugoslav Rep. of Macedonia (August 2015); Dominica, Guyana, Iran, Jamaica & Solomon Islands (September 2015)

(94 countries )Slide8

IPV introduction status and planned introduction

by quarter by the end of 2015

Data source: WHO/IVB Database, as of 01 October 2015

Map production Immunization Vaccines and Biologicals (IVB),

World Health Organization

Date of slide: 1 October 2015

The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.

Introduced to date

(111 countries or 57.2%)

(50 countries or 25.8%)

Introduction planned in Q4 2015

Introduction delayed to 2016 due to global IPV vaccine shortage

Not applicable

(33 countries or 17%)

Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Kiribati, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015)Slide9

bOPV registration

status for routine immunization

Approval for use

(98 countries or 66%)

Review in progress

(15 countries or 10%)

Pending submission

(30 countries or 20%)

Focus countries

Not available/ non switch countries

Not applicable

Data source: WHO/IVB Database, as of 01 October 2015 based on 148 OPV user countries.

Map production Immunization Vaccines and Biologicals (IVB),

World Health Organization

The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.

(

5

countries or

3%)

(46 countries)

Countries of

special

focus are: Belarus,

Bosnia

and

Herzegovina

, Qatar,

Russian

Federation

and Rwanda